ACCESS Newswire
09 Aug 2022, 17:55 GMT+10
ALPHARETTA, GA / ACCESSWIRE / August 9, 2022 / RushNet, Inc (OTC PINK:RSHN), (the 'Company') is pleased to announce that heliosDX has launched its testing for the Human Monkeypox Virus through its partner laboratory effective today.
With rising concerns and outbreaks of the Human Monkeypox Virus across the U.S., heliosDX has added PCR testing for the virus to its infectious disease panel in collaboration with its laboratory partners to offer services to patients suffering from the virus.
For clinics and practices interested in fast and reliable PCR testing services for this virus and other illnesses please visit our website or contact us directly at 1-833-HELIOS8 (833-435-4678).
For quick access to our testing services, please visit the links below:
heliosDX Account Set Up Form
heliosDX Clinical Bulletin Monkeypox Virus
CDC Preparation and Collection Guidance
Visit heliosDX Document Library to view all our marketing materials, clinical data, and requisitions.
About HeliosDx:
heliosDX is a National Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, and Infectious Disease (PCR). We are contracted in 44 of the lower 48 states and looking to expand our reach and capabilities. We intend to always stay ahead of the curve by continually investing in our infrastructure with the most efficient scientific proven instruments and latest cutting-edge software for patient and physician satisfaction. In management's opinion, following such best practices are intended to allow heliosDX to provide physicians fast and accurate reporting, meeting, and exceeding industry benchmarks. It is our goal to excel in patient and client care through physician designed panels that aid in testing compliance and reporting education.
Contact:
Ashley Sweat
[email protected]
www.heliosdx.com
Twitter Handle: @dx_helios
Safe Harbor Notice
Certain statements contained herein are 'forward-looking statements' (as defined in the Private Securities Litigation Reform Act of 1995). The Company cautions that statements, and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.
Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives -
On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importance of disclosure during the COVID-19 crisis.
The SEC and Self-Regulatory Organizations are targeting public companies that claim to have products, treatment, or other strategies with regard to COVID-19.
The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Additionally, new information may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time.
We further caution investors that our primary focus and goal is to battle this pandemic for the good of the world. As such, it is possible that we may find it necessary to make disclosures which are consistent with that goal, but which may be averse to the pecuniary interests of the Company and of its shareholders.
SOURCE: RushNet, Inc.
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationLONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...
AMSTERDAM, Netherlands: Some 32 percent of global semiconductor production could face climate change-related copper supply disruptions...
NEW YORK, New York - U.S. stocks rebounded Tuesday with all the major indices gaining ground. Markets in the UK, Europe and Canada...
NEW YORK CITY, New York: Financial markets kicked off the week on a cautious note as President Donald Trump rolled out a fresh round...
RIO DE JANEIRO, Brazil: At a two-day summit over the weekend, the BRICS bloc of emerging economies issued a joint declaration condemning...
LONDON, U.K.: This week, BP appointed Simon Henry, former Shell finance chief, to its board as a non-executive director effective September...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
(Photo credit: Kamil Krzaczynski-Imagn Images) Thursday evening's contest between the host Chicago White Sox and Cleveland Guardians...
(Photo credit: Katie Stratman-Imagn Images) Nick Lodolo and four relievers combined on a four-hit shutout Thursday for the host Cincinnati...
(Photo credit: Dustin Safranek-Imagn Images) Austin FC striker Brandon Vazquez will miss the rest of the season with a torn ACL in...
(Photo credit: Kamil Krzaczynski-Imagn Images) The Chicago White Sox certainly would like to start a long winning streak of their...
(Photo credit: Kamil Krzaczynski-Imagn Images) Adrian Houser allowed one run over seven innings to help the Chicago White Sox end...